Drug Profile
NA 16887
Latest Information Update: 16 Aug 2007
Price :
$50
*
At a glance
- Originator Nippon Kayaku
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Cancer
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Bacterial infections in Japan (unspecified route)
- 08 Jun 2001 No-Development-Reported for Cancer in Japan (unspecified route)
- 12 Nov 1998 Preclinical development for Bacterial infections in Japan (unspecified route)